Philip Morris International (PM)
Sells Marlboro cigarettes and IQOS, ZYN, and VEEV smoke-free products.
Something off on this page? Send us feedback.
Sells Marlboro and other cigarettes alongside IQOS heated tobacco, ZYN nicotine pouches, and VEEV e-vapor products worldwide. International smoke-free and combustible operations remain the core, complemented by a U.S. business built around ZYN and IQOS.
Sells Marlboro and other cigarettes alongside IQOS heated-tobacco devices and consumables, ZYN nicotine pouches, and VEEV e-vapor products. International operations span smoke-free and combustible tobacco, while the U.S. business is built around ZYN, IQOS expansion, and the smaller Aspeya oral-wellness unit.
Scale comes from established international cigarette distribution and a smoke-free model combining proprietary devices, recurring consumables, retail trials, consumer care, and digital channels. Cigarettes remain the larger revenue base, even as smoke-free products supply a substantial share.
Performance depends on excise-tax regimes, product and marketing authorizations, litigation outcomes, distributor relationships, and currency movements across markets.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 23, 2026 | UBS | Reiterate | Rating: —Target: $182 | Target: $192 |
| Jul 29, 2026 | Barclays | Reiterate | Rating: —Target: $205 | Target: $225 |
| Jul 24, 2026 | BTIG | Reiterate | Rating: —Target: $216 | Target: $221 |
| Jul 23, 2026 | Stifel Nicolaus | Target | Target: $195 | Target: $205 |
| Jul 23, 2026 | Needham | Reiterate | Rating: —Target: — | Target: $215 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $6.00B · Total debt $49.11B · Total assets $68.27B · Shareholders' equity −$8.58B
- Revenue
- $11.19B
- Operating income
- $4.53B
- Net income
- $2.82B
HistoryDividendAnnual yieldUpcoming
| Institutions | 84.42% | 1.32B shares | |
|---|---|---|---|
| 3,008 holders · as of Jun 30, 2026 | |||
| Insiders | 0.17% | 2.66M shares | |
| 22 holders · as of Aug 3, 2026 | |||
| Strategic holders | 6.04% | 94.11M shares | |
| 1 holder · as of Feb 3, 2022 | |||
| Other | 9.37% | 146.03M shares | |
| remainder | |||
1.56B company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Capital World InvestorsInstitution | 8.54% | 133.15M | as of Jun 30, 2026 |
BlackRock, Inc.Institution | 6.93% | 108.04M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.53% | 101.79M | as of Jun 30, 2026 |
BlackRock, Inc.Strategic | 6.04% | 94.11M | filed Feb 3, 2022 |
Capital Research Global InvestorsInstitution | 5.41% | 84.25M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Feb 19, 2026 | Frederic de Wilde | officer: CEO PMI International | −20,000 | $182.58 |
| Feb 19, 2026 | Jacek Olczak | director, officer: Group CEO PMI | −80,000 | $182.18 |
| Feb 20, 2026 | Stacey Kennedy | officer: CEO PMI U.S. | −14,350 | $183.13 |
| Feb 19, 2026 | Yann Guerin | officer: Group Chief Legal Officer | −4,000 | $181.69 |
| Feb 20, 2026 | Reginaldo Dobrowolski | officer: Group Controller | −6,000 | $183.48 |
- Altria Group
Former parent; US rival across oral nicotine, combustibles, and heated tobacco.
- British American Tobacco (ADR)
Full-portfolio global rival; #2 in HTT, Vuse vapor leader, Velo pouches.
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Philip Morris International | $191.57 | +0.70% | $296.49B | 27.3 | 21.8 | 7.0 | +10.4% |
| Altria Group | $69.20 | +0.81% | $114.64B | 14.5 | 12.0 | 5.2 | +1.3% |
| British American Tobacco (ADR) | $55.66 | −0.17% | $120.25B | 14.4 | — | 3.5 | −0.1% |
| Median | 14.5 | 12.0 | 4.4 | +0.6% |